5-Amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid

Catalog No. :
ACZJLW380
CAS No. :
2635-64-5
Molecular Formula :
C13H13N3O5
Molecular Weight :
291.26

IUPAC Name:5-amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid

5-Amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid
IUPAC Name5-amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid
Molecular FormulaC13H13N3O5
Molecular Weight291.26
SMILESO=C(O)C(N(C(C1=C2C=CC=C1N)=O)C2=O)CCC(N)=O
InChI KeyXSKMMEVRGHPMSJ-UHFFFAOYSA-N
Synonym5-amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid;Pomalidomide Impurity J;Hydrolyzed Pomalidomide M11;CC-8017;Pomalidomide Hydrolyzed M11;2H-Isoindole-2-acetic acid, 4-amino-α-(3-amino-3-oxopropyl)-1,3-dihydro-1,3-dioxo-;4-Amino-a-(3-amino-3-oxopropyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetic acid;6-amino-2-(4-amino-1,3-dioxoisoindolin-2-yl)-6-oxohexanoic acid
CAS No.2635-64-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZJLW380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZJLW380 route product structure diagram
    ACZJLW3802635-64-5
Inquiry

2. ACZJLW380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZJLW380 route product structure diagram
    ACZJLW3802635-64-5
Inquiry

Comments (0)